CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
- Author(s)
- Pal, SK; Tran, B; Haanen, Jbag; Hurwitz, ME; Sacher, A; Tannir, NM; Budde, LE; Harrison, SJ; Klobuch, S; Patel, SS; Meza, L; Dequeant, ML; Ma, A; He, QA; Williams, LM; Keegan, A; Gurary, EB; Dar, H; Karnik, S; Guo, C; Heath, H; Yuen, RR; Morrow, PK; Agarwal, N; Srour, SA;
- Journal Title
- Cancer Discovery
- Publication Type
- Research article
- Abstract
- Therapeutic approaches for clear cell renal cell carcinoma (ccRCC) remain limited; however, chimeric antigen receptor (CAR) T-cell therapies may offer novel treatment options. CTX130, an allogeneic CD70-targeting CAR T-cell product, was developed for the treatment of advanced or refractory ccRCC. We report that CTX130 showed favorable preclinical proliferation and cytotoxicity profiles and completely regressed RCC xenograft tumors. We also report results from 16 patients with relapsed/refractory ccRCC who received CTX130 in a phase I, multicenter, first-in-human clinical trial. No patients encountered dose-limiting toxicity, and disease control was achieved in 81.3% of patients. One patient remains in a durable complete response at 3 years. Finally, we report on a next-generation CAR T construct, CTX131, in which synergistic potency edits to CTX130 confer improved expansion and efficacy in preclinical studies. These data represent a proof of concept for the treatment of ccRCC and other CD70+ malignancies with CD70-targeted allogeneic CAR T cells. SIGNIFICANCE: Although the role of CAR T cells is well established in hematologic malignancies, the clinical experience in solid tumors has been disappointing. This clinical trial demonstrates the first complete response in a patient with RCC, reinforcing the potential benefit of CAR T cells in the treatment of solid tumors.
- Publisher
- American Association for Cancer Research
- Department(s)
- Medical Oncology
- Publisher's Version
- https://doi.org/10.1158/2159-8290.Cd-24-0102
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-17 04:32:34
Last Modified: 2024-07-17 04:35:46